Kimia Biosciences gets permission to manufacture, sell new API ‘Brivaracetam’

23 Feb 2021 Evaluate

Kimia Biosciences has been granted permission to manufacture new API for sale or for distribution namely Brivaracetam by Central Drugs Standard Control Organization, Ministry of Health & Family Welfare, FDA Bhawan, New Delhi, dated February 15, 2021 in FORM CT-22 under Drugs & Cosmetics Acts & Rules thereunder. 

Kimia Biosciences is a pharmaceutical company and the state of the art manufacturing facility is manufacturing latest Bulk Drugs and intermediates (R&D based) for India and Overseas markets.

Kimia Biosciences Share Price

35.87 0.71 (2.02%)
02-Jan-2026 10:43 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1729.70
Dr. Reddys Lab 1247.55
Cipla 1510.00
Zydus Lifesciences 915.95
Lupin 2109.05
View more..
Register Now to get our Free Newsletter & much more!

© 2026 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×